New botox lasts longer for voice disorder patients
NCT ID NCT05158166
First seen Mar 30, 2026 · Last updated May 20, 2026 · Updated 4 times
Summary
This study tested a new type of botulinum toxin (daxibotulinumtoxinA) in 22 adults with adductor spasmodic dysphonia, a condition that causes voice spasms. The goal was to see if it works as well as standard Botox but lasts longer, so patients need fewer injections. Participants received one injection into the voice box muscles and were monitored for voice improvement and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPASMODIC DYSPHONIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UCSF
San Francisco, California, 94118, United States
Conditions
Explore the condition pages connected to this study.